Technological Advances, Precision Medicine and Regulatory Improvements in Drug Safety and Pharmacy Support
A special issue of Healthcare (ISSN 2227-9032).
Deadline for manuscript submissions: 1 November 2025 | Viewed by 235
Special Issue Editor
Interests: neuropsychopharmacology; neuroscience; GABA; glutamate; pharmacogenetics; pharmacotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Advances in drug safety and pharmacy support have evolved rapidly due to regulatory improvements, technological innovation and a deeper understanding of pharmacology. These advances aim to ensure the safety, efficacy and availability of medicines while reducing the risks associated with drug use. Key developments here revolve around the topics of pharmacovigilance and real-world data, precision medicine, therapeutic drug monitoring (TDM), and artificial intelligence and machine learning in drug safety. Furthermore, regulatory authorities, such as the FDA and EMA, have been enhancing their post-marketing surveillance systems.
The future of drug safety and pharmacy support is bright, with technological advances, tailored pharmacotherapy and regulatory improvements continuing to have a significant impact. From AI-driven safety monitoring to precision medicine, these innovations help ensure that drugs are used safely and effectively, ultimately improving patient outcomes.
This Special Issue aims to bring together experts to share cutting-edge research or reviews on drug safety and pharmacy support. All types of clinical studies that improve patient care and management, including (but not limited to) those on pharmacovigilance, precision medicine, therapeutic drug monitoring (TDM), regulatory improvements and post-marketing surveillance, and artificial intelligence and machine learning in drug safety, are welcome.
We look forward to receiving your contributions.
Prof. Dr. Janko Samardžić
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug safety
- pharmacovigilance
- precision medicine
- therapeutic drug monitoring
- post-marketing surveillance
- artificial intelligence
- machine learning
- clinical pharmacology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
